ASX-listed consumer healthcare company Wellnex Life Ltd (ASX: WNX) is planning to gain an additional quotation on AIM. It currently has a market capitalisation of A$20m.
The company was originally a dairy products business but subsequently moved into consumer healthcare. This has been the focus since 2021.
Wellnex Life has an agreement with Haleon to supply paracetamol products under the Panadol brand. This deal has been expanded outside of Australia and includes the UK and the UAE. There are partnerships with other major pharmaceutical companies. Wellnex Life also has its own brand Pai...
